Similar articles

• Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.

  Marescau B, De Deyn PP, Lowenthal A, Qureshi IA, Antonozzi I, Bachmann C, Cederbaum SD, Cerone R, Chamoles N, Colombo JP, et al. Marescau B, et al. Pediatr Res. 1990 Mar;27(3):297-303. doi: 10.1203/00006450-199003000-00020. Pediatr Res. 1990. PMID: 1690873
• A new case of argininaemia without spastic diplegia in a Portuguese male.

  Vilarinho L, Senra V, Vilarinho A, Barbosa C, Parvy P, Rabier D, Kamoun P. Vilarinho L, et al. J Inherit Metab Dis. 1990;13(5):751-2. doi: 10.1007/BF01799578. J Inherit Metab Dis. 1990. PMID: 2246859 No abstract available.
• Hyperargininemia, epilepsy and the metabolism of guanidino compounds.

  Wiechert P, Marescau B, De Deyn PP, Lowenthal A. Wiechert P, et al. Padiatr Grenzgeb. 1989;28(2):101-6. Padiatr Grenzgeb. 1989. PMID: 2657590 Review.
• Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

  Cederbaum SD, Moedjono SJ, Shaw KN, Carter M, Naylor E, Walzer M. Cederbaum SD, et al. J Inherit Metab Dis. 1982;5(2):95-9. doi: 10.1007/BF01800000. J Inherit Metab Dis. 1982. PMID: 6820432
• Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review.

  Prasad AN, Breen JC, Ampola MG, Rosman NP. Prasad AN, et al. J Child Neurol. 1997 Aug;12(5):301-9. doi: 10.1177/088307389701200502. J Child Neurol. 1997. PMID: 9378897 Review.